Similarly, previous study has indicated possible binding of κOR selective opioid agonist ethylketocyclazocine with SSTRs and modulation of downstream signaling pathway in hepatocellular carcinoma (HepG2) cells [65]. Here, OPRK1 is linked to hepatocellular carcinoma.